Previous 10 | Next 10 |
2024-01-19 09:07:26 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Wayfair (NYSE: W ) layoffs are a hot topic on Friday as the e-commerce company announces major cuts to its workforce to streamline operations. That has the company cutting 1,6...
2024-01-19 08:50:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Esperion Therapeutics (NASDAQ: ESPR ) stock is falling on Friday after the pharmaceutical company announced details for a public offering of its shares. This public offering has...
2024-01-19 08:38:04 ET More on pr-market losers & stocks. MorphoSys: Positive Pelabresib Data Finally Unlocking Upside MorphoSys: A Buying Opportunity Following Mixed Phase 3 Results In Myelofibrosis MorphoSys: Buying Constellation Was A Desperate Measure ...
2024-01-19 07:59:00 ET Summary Congress passes stopgap spending bill to avert government shutdown and buy more time for funding negotiations. Prices of diabetes drugs Mounjaro and Ozempic see increases, along with hundreds of other drugs. Nasdaq 100 reaches all-time high, driv...
2024-01-19 05:00:03 ET Related stock stories: Amazon's Reality Check All Details About Amazon's Valuation After The Huge Run Super Micro: Deteriorating Growth And Margins Means It's Time To Trim (Downgrade) For further details see: Biggest stock movers to...
2024-01-19 02:45:13 ET More on Esperion Therapeutics Esperion Is Sitting On A Potential Blockbuster Drug Esperion: Navigating The 'Bemp' Of Success Amidst Market Waves And Legal Tides Esperion announces proposed public offering of common stock FDA updates lab...
ANN ARBOR, Mich., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (“Esperion”, “we”, “us” or “our”) (Nasdaq: ESPR) announced today the pricing of its previously announced underwritten public offering of 56,700,000 shares of its...
2024-01-18 16:03:41 ET More on Esperion Therapeutics Esperion Is Sitting On A Potential Blockbuster Drug Esperion: Navigating The 'Bemp' Of Success Amidst Market Waves And Legal Tides Esperion Therapeutics, Inc. (ESPR) Q3 2023 Earnings Call Transcript FDA upd...
ANN ARBOR, Mich., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (“Esperion”, “we”, “us” or “our”) (Nasdaq: ESPR) announced today that it has commenced an underwritten public offering of shares of its common stock. In connecti...
2024-01-11 12:25:51 ET DENVER, Colo., Jan. 11, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Atreca (NASDAQ: BCEL), Sealsq (NASDAQ: LAES), Canaan (NASDAQ: CAN), Moolec Science (NASDAQ: MLEC), Osc...
News, Short Squeeze, Breakout and More Instantly...
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
NASDAQ Market:
Esperion Therapeutics Inc. Website:
ANN ARBOR, Mich., July 25, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report second quarter 2024 financial results before the market opens on Monday, August 12, 2024. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financi...
ANN ARBOR, Mich., July 24, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the BTIG Biotech Conference on Monday, August 5, 2024, at 4 p.m. ET. Esperion Therapeutics At Esperion, we discover, develop, and commercialize innovat...
– Targeted Campaign Reaches Patients at Risk for Heart Attack or Heart Procedures Because of High LDL Cholesterol (LDL-C) – – Animated Characters Are a Visual Representation of An Unseen Risk “Lurking” In Patients’ Artery Walls &...